CCL2 and colitis: Reactivation of quiescent colitis was associated with a significant increase of M1 macrophage markers [inducible nitric oxide synthase (iNOS) and monocyte chemoattractant protein-1 (Mcp1)], which was significantly downregulated by hCTS treatment (Figures 4A,B).